Berrylyzer-an Efficient, Traceable, and Lightweight Intelligent Agentic System for Prenatal Genetic Diagnosis
Berrylyzer — эффективная, трассируемая и легковесная интеллектуальная агентная система для пренатальной генетической диагностики
2026-04-04
SCID: 54.1/382w9wak
Discuss with AI
Berrylyzerfree-text clinical narrativesphenotypic and genomic evidenceprenatal genetic diagnosisvariant prioritization
Figures from the paper
Abstract (AI)
Abstract Background Artificial intelligence (AI)-driven variant prioritization has demonstrated substantial utility in expediting genetic diagnosis by ranking the most likely causative variants. While a variety of tools have been developed, few address the unique clinical and technical constraints in prenatal genetic diagnosis. Methods We introduce Berrylyzer, a novel, end-to-end variant prioritization system applied to prenatal diagnosis. Inspired by clinician’s reasoning process during variant interpretation, Berrylyzer applies a modular, stepwise scoring architecture that jointly integrates phenotypic and genomic evidence and delivers a ranked list of candidate variants, achieving high computational efficiency without compromising analytical rigor. Moreover, Berrylyzer natively supports both structured ontologies and free-text clinical narratives, enabling flexible integration into diverse clinical environments. Its performance was rigorously evaluated across two independent, real-world prenatal cohorts and benchmarked against three state-of-the-art methods: Xrare, Exomiser, and PhenIX. Results Across the two datasets, Berrylyzer ranked 56.41% and 58.12% of diagnostic variants first, and achieved recall rates of 94.02% and 97.42% within top 20, respectively. Berrylyzer outperformed Xrare (85.19% and 87.08%), Exomiser (84.90% and 85.98%), and PhenIX (82.05% and 88.93%). Stratified analysis consistently demonstrated superior performance across diverse disease categories, inheritance patterns, and analytical strategies. Notably, Berrylyzer exhibited robustness regardless of phenotype forms, yielding comparable top 20 recall rates for free-text descriptions and standardized terminologies. Conclusion Berrylyzer represents an accurate, interpretable, and computationally lightweight variant prioritization system for prenatal genetic diagnosis. The superior performance across heterogeneous diagnostic contexts enables it as a practical solution for seamless integration into clinical pipelines, thereby advancing precision medicine in prenatal settings.
Key Findings
1
Across two independent real-world prenatal cohorts, Berrylyzer ranked diagnostic variants first in 56.41% and 58.12% of cases.
2
Berrylyzer achieved top-20 recall rates of 94.02% and 97.42%, outperforming Xrare, Exomiser, and PhenIX on both datasets.
3
Berrylyzer is an end-to-end prenatal variant-prioritization system using modular stepwise scoring to jointly integrate phenotypic and genomic evidence.
4
Berrylyzer maintained comparable top-20 recall for free-text clinical descriptions and standardized terminologies, while remaining computationally lightweight and interpretable.
5
Stratified analyses showed consistently superior performance across disease categories, inheritance patterns, and analytical strategies.
Research Object
prenatal genetic diagnosis, specifically candidate genetic variants evaluated using phenotypic and genomic evidence
Research Subject
the accuracy, efficiency, robustness, and ranking performance of variant prioritization across diverse phenotype representations, disease categories, inheritance patterns, and analytical contexts
Publication Details
Publication Date
2026-04-04
Journal
Publisher
ISSN
Cited by
1
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest